Suppr超能文献

[成人先天性代谢缺陷]

[Inborn errors of metabolism in adults].

作者信息

Saudubray J-M, Sedel F

机构信息

Fédération des maladies du système nerveux, hôpital de la Pitié-Salpêtrière, 75013 Paris, France.

出版信息

Ann Endocrinol (Paris). 2009 Mar;70(1):14-24. doi: 10.1016/j.ando.2008.12.004.

Abstract

We present a simplified classification of treatable inborn errors of metabolism (IEM) in three groups with a special focus on those disorders observed at adult age. Group 1 includes inborn errors (IE) of intermediary metabolism which give rise to an acute or chronic intoxication. It encompasses aminoacidopathies, organic acidurias (OA), urea cycle disorders (UCD), sugar intolerances, metal storage disorders and porphyrias. Clinical expression can be acute, systemic or involves a specific organ, it can strike in the neonatal period or later and intermittently from infancy to late adulthood. Most of these disorders are treatable and require the emergency removal of the toxin by special diets, extracorporeal procedures, cleansing drugs or vitamins. Group 2 includes IE of intermediary metabolism which affect the cytoplasmic and mitochondrial energetic processes. Cytoplasmic defects encompass those affecting glycolysis, glycogenosis, gluconeogenesis, creatine and pentose phosphate pathways; the latter are untreatable. Mitochondrial defects include respiratory chain disorders, Krebs cycle and pyruvate oxidation defects, mostly untreatable, and disorders of fatty acid oxidation and ketone bodies that are treatable. Group 3 involves cellular organelles and include lysosomal, peroxisomal, glycosylation, and cholesterol synthesis defects. Among these, some lysosomal disorders can be efficiently treated by enzyme replacement or substrate reduction therapies. Physicians can be faced with the possibility of a treatable IE in emergency, either in the neonatal period or late in infancy to adulthood, or as chronic and progressive symptoms, general (failure to thrive), neurological, or specific for various organs or systems. These symptoms and the simplified classification of IEM are summarized in seven tables.

摘要

我们提出了一种可治疗的先天性代谢缺陷(IEM)的简化分类,分为三组,特别关注在成人期出现的那些疾病。第一组包括中间代谢的先天性缺陷(IE),这些缺陷会导致急性或慢性中毒。它包括氨基酸病、有机酸尿症(OA)、尿素循环障碍(UCD)、糖不耐受、金属贮积病和卟啉病。临床表现可以是急性的、全身性的或涉及特定器官,可在新生儿期或更晚出现,从婴儿期到成年后期呈间歇性发作。这些疾病大多是可治疗的,需要通过特殊饮食、体外程序、解毒药物或维生素紧急清除毒素。第二组包括影响细胞质和线粒体能量代谢过程的中间代谢IE。细胞质缺陷包括影响糖酵解、糖原贮积症、糖异生、肌酸和磷酸戊糖途径的缺陷;后者是不可治疗的。线粒体缺陷包括呼吸链障碍、三羧酸循环和丙酮酸氧化缺陷(大多不可治疗)以及脂肪酸氧化和酮体紊乱(可治疗)。第三组涉及细胞器,包括溶酶体、过氧化物酶体、糖基化和胆固醇合成缺陷。其中,一些溶酶体疾病可以通过酶替代或底物减少疗法得到有效治疗。医生在紧急情况下可能会遇到可治疗的IE,无论是在新生儿期,还是在婴儿后期到成年期,或者表现为慢性进行性症状,如全身症状(发育不良)、神经症状或各种器官或系统的特异性症状。这些症状和IEM的简化分类总结在七个表格中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验